Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
July 31, 2026 4.926M
April 30, 2026 8.632M
January 31, 2026 10.97M
October 31, 2025 12.64M
July 31, 2025 15.00M
April 30, 2025 17.10M
January 31, 2025 17.35M
October 31, 2024 23.44M
July 31, 2024 23.78M
April 30, 2024 25.97M
January 31, 2024 37.29M
October 31, 2023 37.48M
July 31, 2023 40.91M
April 30, 2023 42.62M
January 31, 2023 45.78M
October 31, 2022 45.26M
July 31, 2022 51.70M
April 30, 2022 58.91M
January 31, 2022 37.50M
October 31, 2021 41.06M
July 31, 2021 44.41M
April 30, 2021 46.27M
January 31, 2021 25.25M
October 31, 2020 23.31M
July 31, 2020 14.87M
Date Value
April 30, 2020 10.86M
January 31, 2020 10.93M
October 31, 2019 11.11M
July 31, 2019 11.96M
April 30, 2019 13.43M
January 31, 2019 15.12M
October 31, 2018 15.72M
July 31, 2018 9.408M
April 30, 2018 9.909M
January 31, 2018 8.269M
October 31, 2017 8.218M
July 31, 2017 1.973M
April 30, 2017 2.261M
January 31, 2017 2.934M
June 30, 2016
March 31, 2016
December 31, 2015 -0.173M
September 30, 2015 -0.1641M
June 30, 2015 -0.1668M
March 31, 2015 -0.1698M
December 31, 2014 -0.18M
September 30, 2014 -0.1962M
June 30, 2014 -0.1748M
March 31, 2014 -0.1432M
December 31, 2013 -0.1517M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Repligen Corp. 2.112B
Bio-Techne Corp. 2.108B
BioLife Solutions, Inc. 420.00M
Maravai Lifesciences Holdings, Inc. 204.62M
MaxCyte, Inc. 158.75M

Shareholders Equity (Quarterly) Related Metrics